8 results match your criteria: "USA. freeman@eyecenter.ucsd.edu[Affiliation]"

Comparison of conventional color fundus photography and multicolor imaging in choroidal or retinal lesions.

Graefes Arch Clin Exp Ophthalmol

April 2018

Department of Ophthalmology, Jacobs Retina Center at the Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA.

Purpose: Our purpose was to compare the characteristics of the retinal and choroidal lesions including choroidal nevus, choroidal melanoma and congenital hypertrophy of the retina pigment epithelium using conventional color fundus photography (CFP) and multicolor imaging (MCI).

Methods: The paired images of patients with retinal or choroidal lesions were assessed for the visibility of lesion's border, halo and drusen using a grading scale (0-2). The area of the lesion was measured on both imaging modalities.

View Article and Find Full Text PDF

High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.

Graefes Arch Clin Exp Ophthalmol

October 2017

Department of Ophthalmology, Jacobs Retina Center at the Shiley Eye Institute, University of California San Diego, 94093 Campus Point Drive, La Jolla, CA, 92037, USA.

View Article and Find Full Text PDF

Erratum to: High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.

Graefes Arch Clin Exp Ophthalmol

July 2017

Department of Ophthalmology, Jacobs Retina Center at the Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA.

View Article and Find Full Text PDF

High-frequency aflibercept injections in persistent neovascular age-related macular degeneration.

Graefes Arch Clin Exp Ophthalmol

April 2017

Department of Ophthalmology, Jacobs Retina Center at the Shiley Eye Institute, University of California San Diego, La Jolla, CA, USA.

Purpose: To report the 1-year outcomes of every-4-weeks (Q4W) as-needed aflibercept treatment in resistant neovascular age-related macular degeneration (nAMD) patients who had been treated and failed prior bevacizumab or ranibizumab injections, and who also responded poorly to every-8-weeks (Q8W) aflibercept treatment.

Methods: Forty-three eyes of 39 patients with persistent nAMD despite monthly bevacizumab and/or ranibizumab injections and who were switched to Q8W 2-mg aflibercept injections, but showed persistence of fluid were included. Patients were treated with as-needed Q4W aflibercept injections with monthly monitoring.

View Article and Find Full Text PDF

Effect of change in drusen evolution on photoreceptor inner segment/outer segment junction.

Retina

September 2012

Department of Ophthalmology, University of California, San Diego, La Jolla, California 92037, USA.

Purpose: To evaluate the integrity of photoreceptor inner segment/outer segment (IS/OS) junction after change of drusen size in age-related macular degeneration using spectral-domain optical coherence tomography.

Methods: Drusen volume raster scans were performed with the Spectralis spectral-domain optical coherence tomography (Heidelberg Engineering) through 2,624 drusen in 14 eyes with clinically dry age-related macular degeneration, which had been longitudinally followed-up between 23 and 28 months without intervention (mean, 26.3 months).

View Article and Find Full Text PDF

Prognosti implications of pigment epithelial detachment in bevacizumab (avastin)-treated eyes with age-related macular degeneration and choroidal neovascularization.

Retina

October 2011

Department of Ophthalmology, Jacobs Retina Center at Shiley Eye Center, University of California San Diego, La Jolla, California 92037, USA.

Purpose: To evaluate the response to primary bevacizumab treatment of eyes with age-related macular degeneration (AMD) and choroidal neovascularization (CNV) with a large pigment epithelial detachment (PED) component and to compare the increase in visual acuity and reabsorption of retinal fluid in PED eyes with eyes with CNV in AMD with a minimal to no PED component.

Methods: We reviewed 43 consecutive eyes with CNV and AMD on primary bevacizumab therapy. There were 13 eyes with a large PED component in AMD with CNV and 30 eyes with a minimal to no PED in CNV.

View Article and Find Full Text PDF

Vision function in HIV-infected individuals without retinitis: report of the Studies of Ocular Complications of AIDS Research Group.

Am J Ophthalmol

March 2008

Joan and Irwin Jacobs Retina Center, Department of Ophthalmology, University of California, San Diego, La Jolla, California 92037, USA.

Purpose: To evaluate the prevalence and risk factors for vision loss in patients with clinical or immunologic AIDS without infectious retinitis.

Design: A prospective, multicenter cohort study of patients with AIDS.

Methods: One thousand three hundred and fifty-one patients (2,671 eyes) at 19 clinical trials centers diagnosed with AIDS but without major ocular complications of HIV.

View Article and Find Full Text PDF

Scanning laser entoptic perimetry for the detection of age-related macular degeneration.

Arch Ophthalmol

November 2004

The Jacobs Retina Center, Department of Ophthalmology, University of California, San Diego, Shiley Eye Center, La Jolla, CA 92093-0946, USA.

Objective: To determine the sensitivity and specificity of scanning laser entoptic perimetry for detecting visual function damage due to age-related macular degeneration (ARMD).

Methods: We measured the presence or absence of visual field disturbances by entoptic perimetry and determined the severity of ARMD based on masked readings of fundus photographs. A prospective masked study comparing the findings of entoptic perimetry with fundus photographs was performed.

View Article and Find Full Text PDF